Amy Novogratz
Co-founder and Managing Partner of Aqua-Spark, a pioneer investment fund for sustainable aquaculture. Aqua-Spark is a global investment fund with a mission to transform the global aquaculture industry into one that is healthier, more sustainable and more accessible. They invest in aquaculture companies across the value chain, from farming operations to alternative feed ingredients, disease battling, technology, all the way to consumer facing aquaculture products. These companies are solving some of the industry’s big challenges while bringing returns that are comparable to today’s traditional industry. The portfolio works as an ecosystem, with the companies agreeing to collaborate on optimal solutions, and working together toward this shared vision of a more efficient global aquaculture industry.
Prior to Aqua-Spark Amy served as director of the TED Conference’s annual TED Prize for almost a decade, leading more than twenty global collaborations across a broad spectrum of sectors, including healthcare, education, science, technology, conservation, art, and activism. With TED, her list of notable projects include: Sylvia Earle’s Mission Blue, Jamie Oliver’s Food revolution, JR’s Inside Out Project, and Bono’s One.org among others. Amy met her partner/ co-founder through ocean conservation work connected to Sylvia Earle’s Mission Blue. With Aqua-Spark Amy serves on the boards of Love the Wild, eFishery, and Xpert Sea and Energaia.
Christian Nordby
Christian Olsen Nordby is a fish-farming analyst in Oslo covering all the major Norwegian salmon farmers. He has also covered Norwegian retail companies at Kepler Cheuvreux. Before joining Kepler Cheuvreux, he was a sell-side high-yield credit analyst at Swedbank covering the shipping and transportation sector. Christian holds a degree in Economics and Business Administration (NHH).
John Coast Sullenger
Dr Ben Burrowes
Dr Kimberley Bishop-Lilly
Prof Christian Willy
Prof Ran Nir-Paz
"I am an Infectious Diseases physician at the Hadassah Hebrew University Medical Center in Jerusalem, Israel. As part of the Infectious Diseases service I support our arthroplasty service which is a referral center from around Israel for the more complicated cases. With that I encounter many patients who have infections which are either chronic or hard to cure using common antibiotics. In order to tackle that we have created an ad-hoc compassionate/ early clinical trial phage treatment center with the Hazan Lab@huji. We already successfully treated one patient and few more are on the way."
Kristin Wannerberger
Kristin holds a Ph.D. in Biophysical Technology from Lund University, Sweden and a M.Sc. Chem. Eng. - Food and Dairy Technology. Kristin has more than 20 years of experience of Pharmaceutical Industry working with development of drugs covering various therapeutical areas and several administration forms. She has had various positions based in Sweden, Denmark and Switzerland and currently holds a position as Director Alliance Management R&D, based in Switzerland. She is directing several alliances in the field of the human microbiota/microbiome.